Why market research is as important for medical devices as it is for drugs
Pre-launch market research is well-established in the pharmaceutical industry, but is this the same for medical devices and diagnostics? Sarah Jones explores.
Read More
Gaining payer insights early in product development to inform studies and pricing
How early is too early? For payer insight to asset development is there such as thing as too early? Sarah Jones explores.
Read More
The unpredictable, yet exciting and transformative world of market research
The path from market access to market research may not seem obvious, Head of Projects, Sarah Jones explores how these two specialisms may be more closely linked that some think.
Read More
Why your research focussed life science consultants are best placed to strengthen client relationships
Is it time for a fresh perspective on who manages your ongoing client relationships? Research focusssed consultants may be the answer you are looking for, and Christie Harper tells you why.
Read More
Pharmaceutical Market Research: How to Secure the Right Panel of Experts
Getting the right mix of experts across a variety of markets to share their insights requires patience and perseverance.
Read More
When Qual starts to look like Quant
Glyn Griffiths look at the challenges of blurring the lines of market research; when qualititative and quantitative research get mixed up.
Read More
Why the Payer Perspective is Important in Due Diligence
When taking into account clinician, patient and market perspectives as part of due diligence, the payer perspective can often be overlooked. Christie Harper discusses why this is a problem.
Read More
Managing GDPR Obligations in Payer and Clinician Research
Christie Harper explains how the GDPR does not prevent collection of relevant data regarding clinicians and payers, as long as over-arching criteria are met.
Read More
Do You Know the Market Opportunity for Your New Life Sciences Asset?
Christie Harper discusses the importance of understanding how your asset fits into the market, including asking if investment in it is even a good idea.
Read More
The Pros and Cons of Digital Apps in the Complex NHS Landscape
Sarah Jones considers the growing push towards adopting and gaining insights from digital solutions and applications.
Read More
Look Up! Shifting focus from development of your health innovation to the likelihood of its NHS adoption
Christie Harper discusses a number of factors tht may influence NHS acceptability of a health innovation, even when the benefits seem obvious at pre-implementation stage.
Read More